Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 162: 1699-1710, 2020 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-32777429

RESUMO

Improved ocular delivery of a poorly soluble anti-glaucoma drug, acetazolamide (ACZ), in a stable nanosuspension (NS) was the main target of the study. The anionic polypeptide, poly-γ-glutamic acid (PG) and the glycosaminoglycan, hyaluronic acid, were used to stabilize ACZ-NS prepared using the antisolvent precipitation (AS-PT) coupled with sonication technique. To endue in site biocompatibility with high tolerability, soya lecithin (SL) phospholipid has been also combined with polyvinyl alcohol (PVA). NS with uniform PS in the range 100-300 nm, high ζ > ±20 mV, and enhanced saturation solubility were produced. Targeting solvent removal with control on future particle growth, post-production processing of NS was done using spray drying. The carriers' composition and amount relative to ACZ-NS were optimized to allow for the production of a redispersible dry crystalline powder. Particles crystallinity was confirmed using X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) in liquid and spray dried NS. The modified Draize test proved the safety and tolerability following application to rabbit eyes accompanying an efficient ocular hypotensive activity using a steroid glaucoma model.


Assuntos
Acetazolamida , Materiais Biocompatíveis/uso terapêutico , Portadores de Fármacos/uso terapêutico , Olho/efeitos dos fármacos , Glaucoma/tratamento farmacológico , Nanopartículas/uso terapêutico , Acetazolamida/administração & dosagem , Acetazolamida/farmacocinética , Animais , Disponibilidade Biológica , Olho/patologia , Glicosaminoglicanos/química , Lecitinas/química , Peptídeos/química , Álcool de Polivinil/química , Coelhos , Glycine max/química
2.
Molecules ; 24(5)2019 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-30866428

RESUMO

Brine, the historically known food additive salt solution, has been widely used as a pickling media to preserve flavor or enhance food aroma, appearance, or other qualities. The influence of pickling, using brine, on the aroma compounds and the primary and secondary metabolite profile in onion bulb Allium cepa red cv. and lemon fruit Citrus limon was evaluated using multiplex metabolomics technologies. In lemon, pickling negatively affected its key odor compound "citral", whereas monoterpene hydrocarbons limonene and γ-terpinene increased in the pickled product. Meanwhile, in onion sulphur rearrangement products appeared upon storage, i.e., 3,5-diethyl-1,2,4-trithiolane. Profiling of the polar secondary metabolites in lemon fruit via ultra-performance liquid chromatography coupled to MS annotated 37 metabolites including 18 flavonoids, nine coumarins, five limonoids, and two organic acids. With regard to pickling impact, notable and clear separation among specimens was observed with an orthogonal projections to least squares-discriminant analysis (OPLS-DA) score plot for the lemon fruit model showing an enrichment of limonoids and organic acids and that for fresh onion bulb showing an abundance of flavonols and saponins. In general, the pickling process appeared to negatively impact the abundance of secondary metabolites in both onion and lemon, suggesting a decrease in their food health benefits.


Assuntos
Citrus/química , Fixadores/farmacologia , Metaboloma/efeitos dos fármacos , Cebolas/química , Sais/farmacologia , Citrus/efeitos dos fármacos , Cumarínicos/análise , Flavonoides/análise , Cromatografia Gasosa-Espectrometria de Massas , Limoninas/análise , Metabolômica/métodos , Cebolas/efeitos dos fármacos , Metabolismo Secundário/efeitos dos fármacos , Microextração em Fase Sólida
3.
Lancet Infect Dis ; 3(6): 338-48, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12781505

RESUMO

The oceans are a unique resource that provide a diverse array of natural products, primarily from invertebrates such as sponges, tunicates, bryozoans, and molluscs, and from marine bacteria and cyanobacteria. As infectious diseases evolve and develop resistance to existing pharmaceuticals, the marine environment provides novel leads against fungal, parasitic, bacterial, and viral diseases. Many marine natural products have successfully advanced to the late stages of clinical trials, including dolastatin 10, ecteinascidin-743, kahalalide F, and aplidine, and a growing number of candidates have been selected as promising leads for extended preclinical assessment. Although many marine-product clinical trials are for cancer chemotherapy, drug resistance, emerging infectious diseases, and the threat of bioterrorism have all contributed to the interest in assessing natural ocean products in the treatment of infectious organisms. In this review, we focus on the pharmacologically tested marine leads that have shown in-vivo efficacy or potent in-vitro activity against infectious and parasitic diseases.


Assuntos
Antibacterianos , Biologia Marinha , Fitoterapia , Animais , Anti-Helmínticos , Antifúngicos , Antiprotozoários , Antituberculosos , Antivirais , Drogas em Investigação , Humanos , Invertebrados
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA